PMID: 9437515Jan 23, 1998Paper

Avascular necrosis following bone marrow transplantation: a case-control study

Bone
J C FinkN S Weiss

Abstract

The role of specific immunosuppressive agents in the development of avascular necrosis (AVN) following hematopoietic stem cell and solid organ transplantation remains unclear. To further explore this question, we conducted a case-control study of patients who underwent bone marrow transplantation (BMT) at the Fred Hutchinson Cancer Research Center. 96 of 1939 long-term survivors transplanted between May 1976 and October 1993 were identified as having AVN. Eight patients were excluded because AVN developed before transplant and one was excluded due to restrictions on reviewing follow-up records. The remaining 87 patients developed AVN a mean of 26.3 +/- 2 months posttransplant and were matched for age, gender, and date of transplant to other BMT recipients. Records were reviewed for corticosteroid and cyclosporine use, pretransplant conditioning with total body irradiation (TBI), and other information including disease for which the transplant was indicated, type of transplant, the occurrence of acute and chronic graft-vs.-host disease, and steroid use prior to transplant. Adjusted odds ratios (ORs) were obtained from conditional logistic regression for 87 matched pairs. Posttransplant steroid use was a risk factor for the occur...Continue Reading

Citations

Jul 6, 2000·Medical and Pediatric Oncology·J KanoldF Deméocq
Mar 20, 2001·Biotechnology and Bioengineering·A W Greenberg, D A Hammer
Jun 24, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C CooperN B Watts
Dec 20, 2003·Pediatric Neurology·J Jeffrey MalatackEliel Bayever
Sep 21, 2000·Transplantation Proceedings·J ToporskiJ Bogusławska-Jaworska
Mar 27, 2001·Transplantation Proceedings·A R TamburT Klein
Jun 12, 2003·Bioorganic & Medicinal Chemistry Letters·Kuo Long YuNicholas A Meanwell
Jun 8, 2001·European Journal of Haematology·S El MarsafyE Gluckman
Apr 5, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Natalia PacienzaJeffrey A Medin
Jun 3, 1999·British Journal of Haematology·A Clark, I M Franklin
Oct 16, 1999·British Journal of Haematology·O Castro
Mar 22, 2001·British Journal of Haematology·C DufourUNKNOWN Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Feb 14, 2002·British Journal of Haematology·Thomas Lehrnbecher, Karl Welte
Jul 9, 2002·British Journal of Haematology·Alison D Leiper
Jul 9, 2002·British Journal of Haematology·Alison D Leiper
Aug 5, 2000·Transfusion·S RendineA M Dall'Omo
Nov 9, 2002·Transfusion·Sabeen AskariJeffrey McCullough
Nov 9, 2002·Transfusion·Dorothy E VawterJeffrey McCullough
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Weiran Chen, Charles D Howell
Oct 22, 1998·The New England Journal of Medicine·J J van Rood, M Oudshoorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.